Not registered yet? Get a free account.

Sign Up
search icon cancel icon

KRS PHARMACEUTICALS PRIVATE LIMITED

www.krspharma.com
Active
Updated: 16 Oct 2025

Krs Pharmaceuticals Private Limited, is an unlisted private company incorporated on 12 September, 2000. It is classified as a private limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 8.46 cr and the total paid-up capital is INR 6.73 cr.

Krs Pharmaceuticals's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 41.29% over the previous year. At the same time, it's book networth has increased by 1.55%.

Read more

Subscription Plans
Industry and products
Manufacturing of Pharmaceuticals
  • Rabeprazole., Esomeprazole Magnesium, Omeprazole Sodium, Esomeprazole, Esomeprazole Zinc, Omeprazole, Esomeprazole Sodium, Omeprazole Magnesium, Pantoprazole
Company size
Auth Capital
₹ 8.5 Cr
Paidup Capital
₹ 6.7 Cr
Revenue
₹ 25-50 cr
# Key metrics of Krs Pharmaceuticals - All rupee values in INR crores. Based on March 2023 numbers. | Metric | Value | Change | |---|---|---| | Auth Capital | ₹ 8.5 Cr | | | Paidup Capital | ₹ 6.7 Cr | | | Revenue | ₹ 25-50 cr | | | Total Revenue | Details available with Tofler Pro subscription | -11.02% | | EBITDA | Details available with Tofler Pro subscription | -41.29% | | Net Profit | Details available with Tofler Pro subscription | -76.86% | | Networth | Details available with Tofler Pro subscription | 1.55% | | Borrowings | Details available with Tofler Pro subscription | 8.07% | | Assets | Details available with Tofler Pro subscription | 13.85% | | Gross Margin | Details available with Tofler Pro subscription | -8.99 | | Operating Margin | Details available with Tofler Pro subscription | -3.78 | | Net Profit Margin | Details available with Tofler Pro subscription | -3.49 | | Return on Equity | Details available with Tofler Pro subscription | -8.44 | | ROCE | Details available with Tofler Pro subscription | -12.66 | | Debt to Equity | Details available with Tofler Pro subscription | 0.0 |
Key Metrics

** All rupee values in INR crores. Based on March 2023 numbers.

Total Revenue
-11.02%
₹ GET PRO
EBITDA
-41.29%
₹ GET PRO
Net Profit
-76.86%
₹ GET PRO
Networth
1.55%
₹ GET PRO
Borrowings
8.07%
₹ GET PRO
Assets
13.85%
₹ GET PRO
Gross Margin
-8.99
GET PRO %
Operating Margin
-3.78
GET PRO %
Net Profit Margin
-3.49
GET PRO %
Return on Equity
-8.44
GET PRO %
ROCE
-12.66
GET PRO %
Debt to Equity
-
GET PRO
Sales
Mar 2023
Net worth
Mar 2023

Locations

indian flag India (5)
State Type Address

location icon Locations on Map

Map placeholder

People

Designation Name DIN/PAN Tenure
Director Narendra Balusu
Shareholder
00378980 21 years
Managing Director Lakshmana Swamy Balusu
Shareholder
01284990 25 years
Director Koneru Chiranjivee Rammohan Rao 02848093 16 years
Director Sai Phani Teja Balusu 08723271 4 years

Financial Highlights

** All numbers in INR crores
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

%
** All numbers in INR crores
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Charges on assets

Bank wise
Charges
1

ICICI Bank Limited

No. of Loans: 3

Total Amount : 21.0 cr

2

Axis Bank Limited

No. of Loans: 1

Total Amount : 0.1 cr

chart icon

Charges

ICICI Bank Limited
Axis Bank Limited

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
CYMA LIFE SCIENCES PRIVATE LIMITED
Active
1.5 Cr 3 Telangana
LAKSHMI COMMUTATORS PVT. LTD.
Under Process of Striking Off
9.9 L 1 Telangana
OCEAN PHARMACOAT PRIVATE LIMITED
Active
78.8 L 3 Telangana
NANDA NANDANA ESTATES & FARMS PRIVATE LIMITED
Active
1.0 L 1 Telangana
BLUE RIBBON TECHNOLOGIES PRIVATE LIMITED
Active
1.0 L 1 Telangana

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Registered Details

CIN

U24239TG2000PTC035234

PAN

AABCK4657M

Incorporation

2000, 25.1 years

Company Email

accounts@krspharma.com

Paid up Capital

₹ 6.7 Cr

Authorised Capital

₹ 8.5 Cr

AGM

Sep 2023

Type

Private
Non-government Company

FAQ - KRS PHARMACEUTICALS PRIVATE LIMITED

What is the incorporation date of KRS PHARMACEUTICALS PRIVATE LIMITED?

plus icon

The incorporation date of KRS PHARMACEUTICALS PRIVATE LIMITED is 12 September, 2000

What is the authorized share capital of KRS PHARMACEUTICALS PRIVATE LIMITED?

plus icon

The authorized share capital of KRS PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 8.5 Cr.

What is the paid-up capital of KRS PHARMACEUTICALS PRIVATE LIMITED?

plus icon

The paid-up capital of KRS PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 6.7 Cr.

What is the registered address of KRS PHARMACEUTICALS PRIVATE LIMITED?

plus icon

The registered address of KRS PHARMACEUTICALS PRIVATE LIMITED is PLOT NO.44, CO-OPERATIVE INDUSTRIAL ESTATE GANDHI NAGAR, BALANAGAR HYDERABAD Telangana - 500037

What is the CIN number of KRS PHARMACEUTICALS PRIVATE LIMITED?

plus icon

The CIN number of KRS PHARMACEUTICALS PRIVATE LIMITED is U24239TG2000PTC035234.

Smart Suggestions

  • Uttar Pradesh
  • Haryana
  • Jammu & Kashmir
  • Punjab
  • Goa
  • Madhya Pradesh
  • Kerala
  • Gujarat
  • Andhra Pradesh
  • Telangana
  • Blog Categories
  • Top Blog post
  • Financial Resources
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More